Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020

Nikolaus Marx, Lars Ryden, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, T. Prashant Nedungadi, Helena W. Rodbard, Per Olav Vandvik, Linong Ji, Wayne Huey Herng Sheu, Eberhard Standl, Oliver Schnell

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

In June 2020, the Taskforce of the Guideline Workshop 2019 convened via teleconferencing to initiate a pilot project that demonstrates the various processes and considerations involved in developing high-quality, evidence-based clinical practice guidelines for the medical management of individuals with type 2 diabetes (T2D) and its associated comorbidities, including cardiovascular disease (CVD) and chronic kidney disease (CKD). The goal of the pilot project was to create evidence-based guidelines for use of sodium-glucose transport protein 2 inhibitors (SGLT2-I) when managing very high risk T2D patients, evidenced by the presence of both CVD and CKD. For this purpose the Taskforce represented a guideline panel and made use of synthesized evidence from an ongoing BMJ Rapid Recommendations project on SGLT2-I and GLP-1 receptor agonists. Results from the Taskforce pilot project demonstrated the value, feasibility and utility of using a step-wise approach to identifying and grading evidence and then developing actionable recommendations for utilizing SGLT2-I in this at-risk T2D population. This report describes the various steps involved in the process and explains how it can be utilized to rapidly develop recommendations in a format that is easy to use and can be quickly updated as new evidence becomes available, also within the emerging concept of living guidelines.

Original languageEnglish (US)
Article number108870
JournalDiabetes Research and Clinical Practice
Volume177
DOIs
StatePublished - Jul 2021

Keywords

  • Cardiovascular disease
  • Chronic kidney disease
  • GLP-1
  • Guidelines
  • MAGICapp
  • SGLT2-I
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020'. Together they form a unique fingerprint.

Cite this